Clinical Trials Directory

Trials / Terminated

TerminatedNCT02503176

An Extension Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome

Status
Terminated
Phase
Phase 3
Study type
Interventional
Enrollment
—
Sponsor
Kissei Pharmaceutical Co., Ltd. · Industry
Sex
All
Age
20 Years
Healthy volunteers
—

Summary

The purpose of this study is to evaluate of the long-term safety and efficacy of KCT-0809 in dry eye patients with Sjögren's syndrome.

Conditions

Interventions

TypeNameDescription
DRUGKCT-0809 ophthalmic solution

Timeline

Primary completion
2017-05-29
First posted
2015-07-20
Last updated
2018-03-05

Locations

1 site across 1 country: Japan

Source: ClinicalTrials.gov record NCT02503176. Inclusion in this directory is not an endorsement.

An Extension Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome (NCT02503176) · Clinical Trials Directory